13
Participants
Start Date
January 31, 2012
Primary Completion Date
June 30, 2013
Study Completion Date
June 30, 2013
growth hormone
GH group intervention: use of GH - initial dose of 0.5 UI/day (0.2 mg/day), with readjustments to 1.0 UI/day (0.4 mg/day) and 1.5 UI/day (0.6 mg/day) after 1 and 2 months of treatment, respectively. The last GH dose will be maintained until the end of the study. These GH dosages were based on the dose used for adults of the same age with GHD. Subjects will be re-evaluated after 6 months of GH therapy or placebo according to muscle strength and body composition .The other group received placebo using the same scheme as the GH group.
Hospital Universitário Clementino Fraga Filho - UFRJ, Rio de Janeiro
Universidade Federal do Rio de Janeiro
OTHER